Concepedia

Author

J. Gregory Cairncross

University of CalgaryORCID

Also Known As

B. J. Fisher, J Cairncross, J G Cairncross, J Gregory Cairncross, J. Cairncross, J. G. Cairncross, J. GREGORY CAIRNCROSS, J. GRegory Cairncross, J. Gregory Cairncross, J.G Cairncross

311

Publications

58K

Citations

74

H-Index

131

Concepts

All Affiliations

University of CalgaryWestern UniversityMassachusetts General HospitalMemorial Sloan Kettering Cancer CenterHarvard University
JG

About

J. Gregory Cairncross is an author at University of Calgary specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

44

76

19.8K

2

Health Sciences

18

24

6.9K

3

Engineering

4

4

417

4

Natural Sciences

2

2

76

5

Public Health

1

1

18

J. Gregory Cairncross

×

143

Publications

55.2K

Citations

66

H-Index

YearCitations

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent,

New England Journal of Medicine

2005

21K

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason,

The Lancet Oncology

2009

7.7K

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia,

New England Journal of Medicine

2005

7.1K

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold,

Journal of Clinical Oncology

1990

2.4K

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas

J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu,

JNCI Journal of the National Cancer Institute

1998

1.6K

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James Perry, Normand Laperrière, Christopher J. O’Callaghan,

New England Journal of Medicine

2017

1.1K

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Catherine L. Nutt, D.R. Mani, Rebecca A. Betensky,

PubMed

2003

959

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia,

Journal of Clinical Oncology

2008

728

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

Thierry Gorlia, Martin J. van den Bent, Monika E. Hegi,

The Lancet Oncology

2007

543

Radation therapy for brain metastases

J. Gregory Cairncross, Jae Ho Kim, Jerome B. Posner

Annals of Neurology

1980

458

Page 1